Clinical Trials Directory

Trials / Sponsors / Viralytics

Viralytics

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedCAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)
Uveal Melanoma, Liver Metastases
Phase 12018-01-29
CompletedIntratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA)
Melanoma
Phase 12015-12-17
CompletedIntratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)
Melanoma
Phase 12015-05-05
CompletedCAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)
Non-muscle Invasive Bladder Cancer
Phase 12015-01-16
CompletedCVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)
Non-small Cell Lung Cancer, Bladder Cancer
Phase 12013-12-18
CompletedCAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)
Melanoma
Phase 22012-07-03
CompletedA Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )
Malignant Melanoma
Phase 22011-12-29
TerminatedA Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients (VLA-X06)
Head and Neck Cancer
Phase 12009-01-27
CompletedCoxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)
Melanoma, Breast Cancer, Prostate Cancer
Phase 12008-02-29
CompletedA Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)
Stage IV Melanoma
Phase 12007-05-16
CompletedIntratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)
Malignant Melanoma
Phase 12005-11-08